Recently, journalist and public health expert David Tuller
documented that the trial suffered from many serious flaws that raise concerns about the validity and accuracy of the reported results. We cited some of these flaws in
an open letter to The Lancet that urged the journal to conduct a fully independent review of the trial. (Dr. Tuller did not sign the open letter, but he is joining us in requesting the trial data.)...
Although the open letter was sent to
The Lancet in mid-November, editor Richard Horton has not yet responded to our request for an independent review. We are therefore requesting that Queen Mary University of London to provide some of the raw trial data, fully anonymized, under the provisions of the U.K.’s Freedom of Information law.
Ronald W. Davis, PhD
Professor of Biochemistry and Genetics
Stanford University
Bruce Levin, PhD
Professor of Biostatistics
Columbia University
Vincent R. Racaniello, PhD
Professor of Microbiology and Immunology
Columbia University
David Tuller, DrPH
Lecturer in Public Health and Journalism
University of California, Berkeley
